(Q40916944)

24 September 2017

Morphometric Analysis of Explant Lungs in Cystic Fibrosis (English)

1 reference

24 September 2017

0 references

15

Marc Decramer

1 reference

24 September 2017

Cindy Mai

6

0 references

Mieke Boon

object named as

Mieke Boon

1

0 references

Stijn E. Verleden

object named as

Stijn E Verleden

2

0 references

Francois Vermeulen

11

object named as

François L Vermeulen

1 reference

24 September 2017

Barbara Bosch

3

1 reference

24 September 2017

Elise J Lammertyn

4

1 reference

24 September 2017

John E McDonough

5

1 reference

24 September 2017

Johny Verschakelen

7

1 reference

24 September 2017

Mariette Kemner-van de Corput

8

1 reference

24 September 2017

Harm A W Tiddens

9

1 reference

24 September 2017

Marijke Proesmans

10

1 reference

24 September 2017

Erik K Verbeken

12

1 reference

24 September 2017

Joel Cooper

13

1 reference

24 September 2017

Dirk E Van Raemdonck

14

1 reference

24 September 2017

Geert M Verleden

16

1 reference

24 September 2017

James C Hogg

17

1 reference

24 September 2017

Lieven J Dupont

18

1 reference

24 September 2017

Bart M Vanaudenaerde

19

1 reference

24 September 2017

Kris De Boeck

20

1 reference

24 September 2017

language of work or name

English

0 references

publication date

9 November 2015

1 reference

American Journal of Respiratory and Critical Care Medicine

24 September 2017

11

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

24 September 2017

193

1 reference

24 September 2017

5

1 reference

24 September 2017

516-526

1 reference

A new era in the treatment of cystic fibrosis: correction of the underlying CFTR defect.

24 September 2017

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201507-1281OC

Origins of cystic fibrosis lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201507-1281OC

Progression of early structural lung disease in young children with cystic fibrosis assessed using CT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201507-1281OC

Bronchiectasis and pulmonary exacerbations in children and young adults with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201507-1281OC

Exacerbations in cystic fibrosis. 1: Epidemiology and pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201507-1281OC

The lung in cystic fibrosis. A quantitative study including prevalence of pathologic findings among different age groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201507-1281OC

Clinical findings and lung pathology in children with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201507-1281OC

Age as a factor in the distribution of lower-airway conductance and in the pathologic anatomy of obstructive lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201507-1281OC

Small-airway obstruction and emphysema in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201507-1281OC

The site and nature of airway obstruction after lung transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201507-1281OC

Cystic fibrosis and pregnancy in the modern era: a case control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201507-1281OC

Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201507-1281OC

Multi-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equations

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201507-1281OC

Effect of bronchoalveolar lavage-directed therapy on Pseudomonas aeruginosa infection and structural lung injury in children with cystic fibrosis: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201507-1281OC

Reproducibility of a scoring system for computed tomography scanning in cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201507-1281OC

The spectrum of structural abnormalities on CT scans from patients with CF with severe advanced lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201507-1281OC

Cystic fibrosis lung disease starts in the small airways: can we treat it more effectively?

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201507-1281OC

Automated CT scan scores of bronchiectasis and air trapping in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201507-1281OC

Family history of adenotonsillectomy as a risk factor for tonsillar hypertrophy and snoring in childhood.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201507-1281OC

Design of peripheral airways for efficient gas exchange.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201507-1281OC

Smaller is better--but not too small: a physical scale for the design of the mammalian pulmonary acinus

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201507-1281OC

Pulmonary changes and cor pulmonale in mucoviscidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201507-1281OC

A morphometric study of mucins and small airway plugging in cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201507-1281OC

Cystic fibrosis pulmonary guidelines. Chronic medications for maintenance of lung health

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201507-1281OC

European Cystic Fibrosis Society Standards of Care: Best Practice guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201507-1281OC

Inhaled antibiotics: dry or wet?

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201507-1281OC

Airway inflammation in cystic fibrosis: molecular mechanisms and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201507-1281OC

10.1164/RCCM.201507-1281OC

21 January 2018

Identifiers

DOI

1 reference

24 September 2017

1 reference